The modification of natural products for medical use

被引:240
作者
Guo, Zongru [1 ,2 ]
机构
[1] Chinese Acad Med Sci, Inst Mat Med, Beijing 100050, Peoples R China
[2] Peking Union Med Coll, Beijing 100050, Peoples R China
关键词
Natural products; Synthesis; Multi-dimensional optimization; Structure-acitivity reactivity; Artemisinin; Indirubin; 2; SGLT2; INHIBITOR; ANTIMALARIAL-DRUG; C-GLUCOSIDE; IN-VITRO; DISCOVERY; POTENT; ANTAGONISTS; ANALOGS; DESIGN; RING;
D O I
10.1016/j.apsb.2016.06.003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Drug innovation is characterized by painstaking molecular-level syntheses and modifications as the basic components of research and development. Similarly, natural products are chemically tailored and modified based upon their structural and biological properties. To some extent, the modification of natural products is quite different from de novo structure-based drug discovery. This review describes the general strategies and principles for the modification of natural products to drugs, as illustrated by several successful medicines that originated from natural products. (C) 2017 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.
引用
收藏
页码:119 / 136
页数:18
相关论文
共 51 条
  • [11] Metabolism-based identification of a potent thrombin receptor antagonist
    Clasby, Martin C.
    Chackalamannil, Samuel
    Czarniecki, Michael
    Doller, Dario
    Eagen, Keith
    Greenlee, William
    Kao, Grace
    Lin, Yan
    Tsai, Hsingan
    Xia, Yan
    Ahn, Ho-Sam
    Agans-Fantuzzi, Jacqueline
    Boykow, George
    Chintala, Madhu
    Foster, Carolyn
    Smith-Torhan, April
    Alton, Kevin
    Bryant, Matthew
    Hsieh, Yunsheng
    Lau, Janice
    Palamanda, Jairam
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (01) : 129 - 138
  • [12] TOTAL SYNTHESIS OF 6-DEMETHYL-6-DEOXYTETRACYCLINE
    CONOVER, LH
    KORST, JJ
    BUTLER, K
    WOODWARD, RB
    JOHNSTON, JD
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1962, 84 (16) : 3222 - &
  • [13] (4-Carboxamido)phenylalanine is a surrogate for tyrosine in opioid receptor peptide ligands
    Dolle, RE
    Machaut, M
    Martinez-Teipel, B
    Belanger, S
    Cassel, JA
    Stabley, GJ
    Graczyk, TM
    DeHaven, RN
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (13) : 3545 - 3548
  • [14] Phlorizin: a review
    Ehrenkranz, JRL
    Lewis, NG
    Kahn, CR
    Roth, J
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2005, 21 (01) : 31 - 38
  • [15] Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors
    Finnin M.S.
    Donigian J.R.
    Cohen A.
    Richon V.M.
    Rifkind R.A.
    Marks P.A.
    Breslow R.
    Pavletich N.P.
    [J]. Nature, 1999, 401 (6749) : 188 - 193
  • [16] Potent immunosuppressants, 2-alkyl-2-aminopropane-1,3-diols
    Fujita, T
    Hirose, R
    Yoneta, M
    Sasaki, S
    Inoue, K
    Kiuchi, M
    Hirase, S
    Chiba, K
    Sakamoto, H
    Arita, M
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (22) : 4451 - 4459
  • [17] SIMPLE COMPOUNDS, 2-ALKYL-2-AMINO-1,3-PROPANEDIOLS HAVE POTENT IMMUNOSUPPRESSIVE ACTIVITY
    FUJITA, T
    YONETA, M
    HIROSE, R
    SASAKI, S
    INOUE, K
    KIUCHI, M
    HIRASE, S
    ADACHI, K
    ARITA, M
    CHIBA, K
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (08) : 847 - 852
  • [18] Epothilons A and B: Antifungal and cytotoxic compounds from Sorangium cellulosum (Myxobacteria) - Production, physico-chemical and biological properties
    Gerth, K
    Bedorf, N
    Hofle, G
    Irschik, H
    Reichenbach, H
    [J]. JOURNAL OF ANTIBIOTICS, 1996, 49 (06) : 560 - 563
  • [19] Empagliflozin, a novel selective sodium glucose cotransporter-2 (SGLT-2) inhibitor: characterisation and comparison with other SGLT-2 inhibitors
    Grempler, R.
    Thomas, L.
    Eckhardt, M.
    Himmelsbach, F.
    Sauer, A.
    Sharp, D. E.
    Bakker, R. A.
    Mark, M.
    Klein, T.
    Eickelmann, P.
    [J]. DIABETES OBESITY & METABOLISM, 2012, 14 (01) : 83 - 90
  • [20] Artemisone -: A highly active antimalarial drug of the artemisinin class
    Haynes, RK
    Fugmann, B
    Stetter, J
    Rieckmann, K
    Heilmann, HD
    Chan, HW
    Cheung, MK
    Lam, WL
    Wong, HN
    Croft, SL
    Vivas, L
    Rattray, L
    Stewart, L
    Peters, W
    Robinson, BL
    Edstein, MD
    Kotecka, B
    Kyle, DE
    Beckermann, B
    Gerisch, M
    Radtke, M
    Schmuck, G
    Steinke, W
    Wollborn, U
    Schmeer, K
    Römer, A
    [J]. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2006, 45 (13) : 2082 - 2088